Dosing begins in Phase 1 trial of VENT-02 therapy for Parkinson’s
Ventus Therapeutics has dosed the first participant in its Phase 1 trial testing VENT-02, a novel oral therapy that…
Articles by Patricia Inácio, PhD
Parkinson’s medications may impair body’s ability to keep cool: Study
Medications commonly used in the treatment of Parkinson’s disease may affect the body’s ability to control its core temperature,…
Acorda launches new campaign, website for Inbrija for Parkinson’s
A new campaign from Acorda Therapeutics encourages people with Parkinson’s disease to consider whether an on-demand treatment, such…
New treatment strategy may boost nerve cell function in Parkinson’s
Researchers have found a novel mechanism through which mutations in a gene called PRKN, linked with early-onset Parkinson’s disease,…
Circulating small vesicles reflect Parkinson’s-related brain changes
Small vesicles that contain the protein alpha-synuclein may help distinguish Parkinson’s disease patients from healthy people, according to a meta-analysis.
Lacosamide, epilepsy drug, shows neuroprotective effects in rat model
Lacosamide, a medication approved to treat epilepsy, showed a potential to be neuroprotective in a rat model of Parkinson’s…
LCIG, DBS show quality of life gains, symptom easing: Real-world study
Parkinson’s disease patients’ quality of life significantly improved with Duopa, a formulation of levodopa and carbidopa infused directly…
Project seeking to enhance patients’ speech awarded 5-year NIH grant
A research project to help enhance communication for individuals with Parkinson’s disease has been awarded a multimillion-dollar grant. The…
Parkinson’s vaccine targets toxic alpha-synuclein in Phase 1 trial
The immune response triggered by UB-312, an experimental vaccine by Vaxxinity, effectively targeted alpha-synuclein protein aggregates and slowed their…
Stem cell therapy for Parkinson’s boosted by immune Tregs: Study
Scientists have shown that co-transplanting stem cells with regulatory T-cells — immune cells known as Tregs that dampen excessive inflammatory…